Shareholder Alert: Ademi LLP investigates whether Pardes Biosciences, Inc. has obtained a Fair Price in its transaction with MediPacific

Provided By PR Newswire

Last update: Jul 17, 2023

MILWAUKEE, July 17, 2023 /PRNewswire/ -- Ademi LLP is investigating Pardes (Nasdaq: PRDS) for possible breaches of fiduciary duty and other violations of law in its transaction with MediPacific.